Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Advanced Platform Technology Center

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Horst Von Recum, PhD


Research interests
Therapeutic delivery of small molecule drugs and biomolecules for chronic and recurrent conditions in
device infection, HIV, orthopedics, cardiovascular, ophthalmology, cancer; and regenerative medicine.
 
Dr. von Recum’s Case Western laboratory research focuses on novel platforms for the delivery of molecules and cells. In the molecular delivery projects, he examines novel affinity-based systems for delivery of therapeutic agents for HIV therapies, wound dressings, ocular disease, localized chemotherapy and other applications. Affinity-based delivery uses molecular interactions to control the rate of release beyond that capable by other means such as diffusion and degradation. This allows for control of delivery to better match the physiological need of the drug.  Further, these devices can be reloaded in vivo with additional drug as needed for continuous or recurrent therapy.

Watch this video to find out more about Dr. von Recum's lab at CWRU


Curriculum Vitae

Pubmed Docs Published Work







Advanced Platform Technology Center